Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

Treatment of Human Immunodeficiency Virus-Infected Lymphocytes with Cationized Human Immunoglobulins

William M. Pardridge, Jody Buciak, Jing Yang and Amadou Diagne
The Journal of Infectious Diseases
Vol. 170, No. 3 (Sep., 1994), pp. 563-569
Published by: Oxford University Press
Stable URL: http://www.jstor.org/stable/30132682
Page Count: 7
  • Download ($42.00)
  • Subscribe ($19.50)
  • Cite this Item
Treatment of Human Immunodeficiency Virus-Infected Lymphocytes with Cationized Human Immunoglobulins
Preview not available

Abstract

Hyperimmune immunoglobulins from human immunodeficiency virus (HlV)-infected persons may inhibit intracellular viral replication if the HIV immunoglobulins (HIVIG) are delivered to intracellular spaces where the virus replicates. This study examines the hypothesis that cationized forms of HIVIG undergo enhanced absorptive-mediated endocytosis into cells and inhibit HIV replication. HIVIG and nonimmune human intravenous immunoglobulin (IVIG) were cationized with hexamethylenediamine to an isoelectric point (pI) <9.5;. Cationization markedly increased the binding and endocytosis of HIVIG and IVIG by human peripheral blood lymphocytes (PBL). Cationized HIVIG and IVIG (250 µg/mL) resulted in a 90% inhibition in p24 released to the medium in HIV-1-infected human PBL. The study demonstrates that cationization of human immunoglobulin preparations, such as HIVIG and IVIG, markedly increases the endocytosis of immunoglobulin and the inhibition of HIV-1 replication in human PBL.

Page Thumbnails

  • Thumbnail: Page 
563
    563
  • Thumbnail: Page 
564
    564
  • Thumbnail: Page 
565
    565
  • Thumbnail: Page 
566
    566
  • Thumbnail: Page 
567
    567
  • Thumbnail: Page 
568
    568
  • Thumbnail: Page 
569
    569